Correlation Between Recursion Pharmaceuticals and CAPITAL

Can any of the company-specific risk be diversified away by investing in both Recursion Pharmaceuticals and CAPITAL at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Recursion Pharmaceuticals and CAPITAL into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Recursion Pharmaceuticals and CAPITAL ONE FINL, you can compare the effects of market volatilities on Recursion Pharmaceuticals and CAPITAL and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Recursion Pharmaceuticals with a short position of CAPITAL. Check out your portfolio center. Please also check ongoing floating volatility patterns of Recursion Pharmaceuticals and CAPITAL.

Diversification Opportunities for Recursion Pharmaceuticals and CAPITAL

-0.34

Correlation Coefficient

Recursion Pharmaceuticals  CAPITAL

Very good diversification

The 3 months correlation between Recursion and CAPITAL is -0.34. Overlapping area represents the amount of risk that can be diversified away by holding Recursion Pharmaceuticals and CAPITAL ONE FINL in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on CAPITAL ONE FINL and Recursion Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Recursion Pharmaceuticals are associated (or correlated) with CAPITAL. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of CAPITAL ONE FINL has no effect on the direction of Recursion Pharmaceuticals i.e., Recursion Pharmaceuticals and CAPITAL go up and down completely randomly.

Pair Corralation between Recursion Pharmaceuticals and CAPITAL

Given the investment horizon of 90 days Recursion Pharmaceuticals is expected to generate 6.46 times more return on investment than CAPITAL. However, Recursion Pharmaceuticals is 6.46 times more volatile than CAPITAL ONE FINL. It trades about 0.07 of its potential returns per unit of risk. CAPITAL ONE FINL is currently generating about 0.04 per unit of risk. If you would invest  650.00  in Recursion Pharmaceuticals on September 12, 2024 and sell it today you would earn a total of  96.00  from holding Recursion Pharmaceuticals or generate 14.77% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	98.41%
Values	Daily Returns

Recursion Pharmaceuticals  vs.  CAPITAL ONE FINL

Recursion Pharmaceuticals

Risk-Adjusted Performance

5 of 100

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in Recursion Pharmaceuticals are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of fairly inconsistent basic indicators, Recursion Pharmaceuticals showed solid returns over the last few months and may actually be approaching a breakup point.

CAPITAL ONE FINL

Risk-Adjusted Performance

3 of 100

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in CAPITAL ONE FINL are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. Despite somewhat strong basic indicators, CAPITAL is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Pair Trading with Recursion Pharmaceuticals and CAPITAL

The main advantage of trading using opposite Recursion Pharmaceuticals and CAPITAL positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Recursion Pharmaceuticals position performs unexpectedly, CAPITAL can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in CAPITAL will offset losses from the drop in CAPITAL's long position.

The idea behind Recursion Pharmaceuticals and CAPITAL ONE FINL pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..